Skip to main content

February 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology

Multiple Myeloma, Oncology
Pomalidomide plus Low-Dose Dexamethasone Combination Likely to Be Cost-Effective
Read More
Perspectives
The Value of Pharmaceuticals and Adherence to Therapy in the Management of Hematologic Cancers
Atheer A. Kaddis, PharmD
Read More
Leukemia, Oncology
Brentuximab Cost-Effective After Transplant
Chase Doyle
Read More
Lymphoma
Stem-Cell Transplant Safe in HIV-Related Lymphoma
Phoebe Starr
Read More
Lymphoma
Posttransplant Brentuximab: New Standard in Hodgkin Lymphoma?
Phoebe Starr
Read More
Leukemia, Oncology
Pediatric Regimen a New Standard for Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Read More
Leukemia, Oncology
CAR-T Achieves High Rate of Remission in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia
Wayne Kuznar
Read More
Leukemia, Oncology
Sorafenib Prolongs Event- and Relapse-Free Survival in Acute Myeloid Leukemia
Read More
Leukemia, Oncology
Pracinostat-Azacitidine Combination Generates Responses in Older Adults with Acute Myeloid Leukemia
Wayne Kuznar
Read More
Multiple Myeloma, Oncology
Dissecting the Treatment Costs of Newly Diagnosed Myeloma in First 2 Years
Read More
Page 1 of 3
Results 1 - 10 of 26